| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 2,804,011 | 3,561,616 | 6,570,382 | 8,039,683 |
| Accounts receivable | 1,897,383 | 2,661,867 | 1,264,805 | 0 |
| Inventory, net | 2,099,415 | 1,666,147 | 2,226,805 | 1,897,701 |
| Deferred offering costs | 22,920 | 22,920 | 22,920 | 0 |
| Prepaid expenses | 283,716 | 154,527 | 141,372 | 233,363 |
| Total current assets | 7,107,445 | 8,067,077 | 10,226,284 | 10,170,747 |
| Intangible assets, net | 33,789 | 39,368 | 44,946 | 50,525 |
| Right-of-use asset | 196,775 | 226,251 | 255,195 | 283,621 |
| Property and equipment, net | 230,596 | 244,906 | 259,222 | 314,588 |
| Total assets | 7,568,605 | 8,577,602 | 10,785,647 | 10,819,481 |
| Accounts payable | 934,196 | 552,332 | 1,010,369 | 467,734 |
| Accrued expenses and other liabilities | 755,258 | 706,112 | 1,292,714 | 958,056 |
| Total current liabilities | 1,689,454 | 1,258,444 | 2,303,083 | 1,425,790 |
| Warrant liability | 709,507 | 806,859 | 1,266,894 | NaN |
| Operating lease liability, long term | 92,361 | 110,374 | 143,148 | 175,344 |
| Warrant liability | NaN | NaN | NaN | 1,040,894 |
| Total liabilities | 2,491,322 | 2,175,677 | 3,713,125 | 2,642,028 |
| Common stock, 0.001 par value 100,000,000 shares authorized 8,615,532 and 8,334,336 shares issued and outstanding as of march 31, 2026 and september 30, 2025, respectively | 8,616 | 50,413 | 50,006 | 49,825 |
| Additional paid-in capital | 87,498,366 | 86,399,189 | 85,632,303 | 85,118,194 |
| Accumulated deficit | -82,429,699 | -80,047,677 | -78,609,787 | -76,990,566 |
| Total stockholders equity | 5,077,283 | 6,401,925 | 7,072,522 | 8,177,453 |
| Total liabilities and stockholders equity | 7,568,605 | 8,577,602 | 10,785,647 | 10,819,481 |
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)